[Novo Nordisk Foundation](https://novonordiskfonden.dk/en/)

June 2, 2026: Full application deadline (call closes)

DKK 1–10 million per grant (total pool: DKK 30 million); project duration 1–5 years

Supports collaborative research projects uniting Steno Diabetes Centers and related institutions to advance diabetes research, care, and prevention.

Main applicant must be from a Steno Diabetes Center or Steno Partner Institution; 2–5 co-applicants required.

--- ## Description This program supports collaborative research projects that bring together Steno Diabetes Centers and associated research environments to enhance knowledge, facilitate experience exchange, and foster synergy in diabetes research. The aim is to promote clinical, patient-centered, and collaborative research, positioning Denmark as a leader in diabetes prevention and care. Projects should focus on clinical research (including translational research, epidemiology, and big data), digital health, continuity in patient care, type-2 diabetes, health promotion, and education. --- ## Due Dates - June 2, 2026: Full application deadline (call closes) - Call opens: April 1, 2026 - Applicant notification: Mid-September 2026 - Earliest project start date: November 1, 2026 - Latest project start date: October 31, 2027 --- ## Funding Amount - Total available: DKK 30 million - Individual grants: DKK 1 million to DKK 10 million - Project duration: 1 to 5 years - Eligible expenses include salaries (excluding main applicant), technical assistance, postdocs, PhD students (including tuition), research-year students, travel, equipment (up to DKK 200,000/year), consumables, communication, publication, administrative costs (up to 5%), and project supplement for Danish universities. - Overhead and main applicant salary are not funded. --- ## Eligibility - **Main Applicant:** Must be employed at a Steno Diabetes Center or a Steno Partner Institution (hospital with a cooperative agreement with a Steno Diabetes Center); PhD students and postdocs are not eligible as main applicants. - **Co-Applicants:** 2–5 required; can be from Steno Centers, hospitals, universities, municipalities, or other non-profit research/diabetes care institutions in Denmark or abroad. International collaboration is encouraged. - **Restrictions:** - In a calendar year, an individual can be main applicant for only one application in Steno Collaborative Project Grants, Project Grants in Endocrinology and Metabolism, or Non-Diabetic Collaborative Grants. - Co-applicants may participate in up to two applications across Steno Collaborative and Non-Diabetic Collaborative Grants. - Applicants may apply before all legal approvals are obtained, but grants cannot be activated until approvals are in place. --- ## Application Process - Applications must be submitted via the [NORMA online system](https://norma.novonordiskfonden.dk). - All application materials and appendices must be in English and uploaded as PDFs. - Required documents include: - Project description (max 20,000 characters) - Brief project and lay summary - CV and publication list for main applicant (CV: short bibliographic overview; Publications: up to 10 key items) - CVs for co-applicants (max two pages each) - Hosting letter from main applicant’s institution (signed by management) - Letters of support from co-applicant institutions (signed) - Only the main applicant can submit the final application, but co-applicants must be invited and complete their sections in NORMA. - Only budget information entered in the NORMA Budget tab will be reviewed. - No feedback is provided for declined applications. - For technical support, contact norma-support@novo.dk. --- ## Additional Information - Projects must clearly demonstrate the collaborative nature and the roles of all applicants. - Main applicants with active Novo Nordisk Foundation grants can apply, but must clarify differences between projects. - Bench fees and administrative costs have specific eligibility rules; see guidelines for details. - All grant recipients must comply with Novo Nordisk Foundation’s [General Terms and Conditions](https://novonordiskfonden.dk/en/how-we-work/what-are-grants/rules-and-policies/). --- ## External Links - [Program page and full call details](https://novonordiskfonden.dk/en/grant/steno-collaborative-grants-2/) - [Guidelines for Applicants (PDF)](https://novonordiskfonden.dk//app/uploads/Guidelines-for-applicants-Steno-Collaborative-Grants-2026-1.pdf) - [NORMA application portal](https://norma.novonordiskfonden.dk) - [General Terms and Conditions](https://novonordiskfonden.dk/en/how-we-work/what-are-grants/rules-and-policies/) - [Frequently Asked Questions](https://novonordiskfonden.dk/en/how-we-work/what-are-grants/faq/) --- ## Contact Information | Name | Role | Email | Phone | |----------------|------------------------|--------------------------|-----------------| | Ursula Bach | Senior Grant Manager | urba@novo.dk | +45 44 44 88 88 | | NORMA Support | Technical support | norma-support@novo.dk | | | General Info | Novo Nordisk Foundation| info@novonordiskfonden.dk| +45 35 27 66 00 | For additional guidance, see the [NORMA Help Centre](https://norma.novonordiskfonden.dk/).

Steno Collaborative Grants

Sign in to see full grant listing